A wave of companies are offering potential solutions that won’t cut the chemicals out of the supply chain but destroy them.
After scrapping plans for an IPO in 2022, Hinge Health Inc. is taking a more favorable view of going public given the increased support seen for health care and med-tech stocks in recent months. The ...
ADWEEK spoke to chief marketing officer and newly appointed president Jackie Jantos about the brand's strategy in an era of ...
Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a key way to keep patients safe. But the FDA’s system for collecting data and ...
Hinge Health files IPO with CEO Daniel Perez holding 19% voting power. Major clients include HCSC, Elevance Health & Aetna.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results